Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

QUENTIN EMERSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1427065341
CMS profile
291550
Location
FORT BRANCH, IN

General Payments · PY2018–2024

$4,954.46

  • Reported across 249 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$759.00

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $759.00 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $261.27 15
Amgen Inc. $232.40 10
Smith & Nephew, Inc. $63.32 2
Axsome Therapeutics, Inc. $46.26 2
ORGANOGENESIS INC. $44.62 2
Lilly USA, LLC $41.50 2
Verity Pharmaceuticals Inc. $29.37 2
ITI, Inc. $24.66 1
Takeda Pharmaceuticals U.S.A., Inc. $15.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $499.15 27
PY2019 $1,046.03 46
PY2020 $449.96 27
PY2021 $755.62 36
PY2022 $765.82 39
PY2023 $678.88 37
PY2024 $759.00 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.43 01/25/2024 Food and Beverage Undisputed 01/23/2026 1117548705 CMS
Amgen Inc. $53.01 02/15/2024 Food and Beverage Undisputed 01/23/2026 1115603071 CMS
Amgen Inc. $53.01 02/15/2024 Food and Beverage Undisputed 01/23/2026 1115603080 CMS
Amgen Inc. $21.42 02/29/2024 Food and Beverage Undisputed 01/23/2026 1117548707 CMS
Amgen Inc. $21.98 04/25/2024 Food and Beverage Undisputed 01/23/2026 1117548709 CMS
Amgen Inc. $4.49 06/12/2024 Food and Beverage Undisputed 01/23/2026 1117548711 CMS
Amgen Inc. $13.04 07/25/2024 Food and Beverage Undisputed 01/23/2026 1117548713 CMS
Amgen Inc. $19.10 08/29/2024 Food and Beverage Undisputed 01/23/2026 1117548715 CMS
Amgen Inc. $14.84 11/14/2024 Food and Beverage Undisputed 01/23/2026 1117548717 CMS
Amgen Inc. $14.08 12/12/2024 Food and Beverage Undisputed 01/23/2026 1117548719 CMS
Axsome Therapeutics, Inc. $17.73 03/21/2024 Food and Beverage Undisputed 01/23/2026 1148312074 CMS
Axsome Therapeutics, Inc. $28.53 05/09/2024 Food and Beverage Undisputed 01/23/2026 1148312076 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.66 04/04/2024 Food and Beverage Undisputed 01/23/2026 1143221807 CMS
Lilly USA, LLC $19.05 06/13/2024 Food and Beverage Undisputed 01/23/2026 1135328656 CMS
Lilly USA, LLC $22.45 10/31/2024 Food and Beverage Undisputed 01/23/2026 1135323161 CMS
Novo Nordisk Inc $5.31 02/02/2024 Food and Beverage Undisputed 01/23/2026 1097245449 CMS
Novo Nordisk Inc $15.51 02/15/2024 Food and Beverage Undisputed 01/23/2026 1096699046 CMS
Novo Nordisk Inc $18.63 02/22/2024 Food and Beverage Undisputed 01/23/2026 1097625144 CMS
Novo Nordisk Inc $16.70 03/14/2024 Food and Beverage Undisputed 01/23/2026 1097253229 CMS
Novo Nordisk Inc $5.29 04/06/2024 Food and Beverage Undisputed 01/23/2026 1096947298 CMS
Novo Nordisk Inc $22.01 04/11/2024 Food and Beverage Undisputed 01/23/2026 1096826858 CMS
Novo Nordisk Inc $23.17 04/18/2024 Food and Beverage Undisputed 01/23/2026 1096598515 CMS
Novo Nordisk Inc $23.99 05/16/2024 Food and Beverage Undisputed 01/23/2026 1097255931 CMS
Novo Nordisk Inc $19.83 05/23/2024 Food and Beverage Undisputed 01/23/2026 1096625187 CMS
Novo Nordisk Inc $15.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 1097099736 CMS
Novo Nordisk Inc $17.46 07/18/2024 Food and Beverage Undisputed 01/23/2026 1096859645 CMS
Novo Nordisk Inc $19.03 08/23/2024 Food and Beverage Undisputed 01/23/2026 1097663574 CMS
Novo Nordisk Inc $14.65 09/26/2024 Food and Beverage Undisputed 01/23/2026 1096638168 CMS
Novo Nordisk Inc $18.91 10/24/2024 Food and Beverage Undisputed 01/23/2026 1096567688 CMS
Novo Nordisk Inc $25.00 12/19/2024 Food and Beverage Undisputed 01/23/2026 1097365150 CMS
Organogenesis Inc. $27.84 03/29/2024 Food and Beverage Undisputed 01/23/2026 1145426518 CMS
Organogenesis Inc. $16.78 04/30/2024 Food and Beverage Undisputed 01/23/2026 1145426520 CMS
Smith+Nephew, Inc. $15.79 02/14/2024 Food and Beverage Undisputed 01/23/2026 1149518317 CMS
Smith+Nephew, Inc. $47.53 05/16/2024 Food and Beverage Undisputed 01/23/2026 1149518319 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.60 02/08/2024 Food and Beverage Undisputed 01/23/2026 1137540290 CMS
Verity Pharmaceuticals Inc. $13.47 08/16/2024 Food and Beverage Undisputed 01/23/2026 1080607289 CMS
Verity Pharmaceuticals Inc. $15.90 09/22/2024 Food and Beverage Undisputed 01/23/2026 1080607293 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.